Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants
Impact of HIV exposure, feeding status, and microbiome on immune ontogeny and vaccine responses in infants
批准号:
10116253
负责人:
Catherine A Blish
金额:
$42.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-11 至 2023-02-28
关键词:
AccountingAcellular VaccinesAddressAdultAffectAgeAntibiotic ProphylaxisAntigensAntiviral AgentsAreaAutomobile DrivingBCG LiveBirthBloodCell modelCellsCellular ImmunityCessation of lifeCharacteristicsChildCohort StudiesCommunicable DiseasesCytotoxic T-LymphocytesDataDevelopmentDiarrheaEnvironmentExclusive BreastfeedingExposure toFailureFecesFoundationsGeneticGrowthHIVHIV InfectionsHIV-exposed uninfected infantHuman MilkHumoral ImmunitiesImmuneImmune responseImmune systemImmunityImmunological ModelsIn VitroInfantInfant DevelopmentInfectionLeadLifeLocalesLocationMothersMucous MembraneNatural IncreasesNatural Killer CellsNeonatalNewborn InfantPertussisPertussis VaccinePhenotypePredispositionPregnant WomenPrevalenceProcessResourcesRespiratory Tract InfectionsRiskRoleRotavirusRotavirus VaccinesSalivaSamplingShapesSouth AfricaSpecimenT cell receptor repertoire sequencingT-LymphocyteT-Lymphocyte SubsetsT-cell diversityVaccinationVaccinesViralVulnerable PopulationsWorkbreast milk microbiomecohortcytokinediarrheal diseasefecal microbiomefeedingfightinggut microbiomehigh riskin uteroinfant infectioninfection rateinfection riskmaternal microbiomemicrobialmicrobiomemortalitymucosal vaccineneonatal immunityneonatal infectionneonatal periodneonatepredictive modelingrespiratoryresponsesaliva samplestool samplesuccesstoolvaccination outcomevaccine responsevaccine-induced immunity
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Each year, approximately 8 million children under the age of five die, and approximately 3.3 million of those
deaths occur in the neonatal period. Infections are the single largest contributor to these deaths, accounting for
an estimated 36% of the mortality. However, our understanding of how the neonatal and infant immune system
influence this susceptibility to infectious diseases is limited. Thus, to elucidate mechanisms that regulate the
development of infant immunity, we propose evaluating immune development in a setting of high risk of
neonatal and infant infection. In particular, infants who are exposed to HIV, yet remain uninfected, suffer
increased rates of respiratory and diarrheal illnesses. Feeding status is also associated with altered risk of
infection, with exclusively breastfed children less likely to suffer diarrheal illness and death. Our preliminary
data suggest that both HIV exposure and feeding status influence the infant microbiome, which is increasingly
recognized for its important role in driving immune development. Thus, to better understand the unique
characteristics of immune development in neonates and infants, we propose evaluating the impact of HIV
exposure and feeding status on the interplay between the microbiome, innate and adaptive cellular immune
ontogeny, and vaccination outcomes. Our preliminary data also suggests that HIV exposure leads to
oligoclonality in the T cell repertoire, potentially narrowing the spectrum of antigens to which infant T cells can
respond. We have also found that HIV infection increases natural killer (NK) cell diversity while decreasing NK
cell cytotoxic function. Using longitudinal samples collected from HIV-exposed uninfected (HEU) and HIV-
unexposed (HU) babies in an area of extremely high HIV prevalence in South Africa, we will: 1) compare the T
and NK cell repertoires and function between HEU and HU babies, 2) determine the impact of maternal HIV,
feeding status, gut and breastmilk microbiome on the infant mucosal microbiome, and 3) build a predictive
model of effective pertussis and rotavirus vaccines to identify the major factors that associate with vaccine
success or failure. This study will provide a comprehensive understanding of how cellular immune responses
and the microbiome evolve in the first year of life and influence the ability to generate an effective cellular and
humoral immune responses.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI:
10.4049/jimmunol.2100503
发表时间:
2022-01-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Dzanibe S, Lennard K, Kiravu A, Seabrook MSS, Alinde B, Holmes SP, Blish CA, Jaspan HB, Gray CM]
通讯作者:
Gray CM
Disrupted memory T cell expansion in HIV-exposed uninfected infants is preceded by premature skewing of T cell receptor clonality.
在暴露于 HIV 的未感染婴儿中,记忆性 T 细胞增殖受到破坏,随后 T 细胞受体克隆性就会过早发生偏差。
DOI:
10.1101/2023.05.19.540713
发表时间:
2023
期刊:
bioRxiv : the preprint server for biology
影响因子:
--
作者:
[Dzanibe,Sonwabile, Wilk,AaronJ, Canny,Susan, Ranganath,Thanmayi, Alinde,Berenice, Rubelt,Florian, Huang,Huang, Davis,MarkM, Holmes,Susan, Jaspan,HeatherB, Blish,CatherineA, Gray,CliveM]
通讯作者:
Gray,CliveM
Pandemic Assistance Core
-
批准号:10514267
-
项目类别:
-
资助金额:$559.9万
-
财政年份:2022
-
负责人:Catherine A Blish
-
依托单位:
Natural killer cell engineering to target the HIV reservoir
-
批准号:10380777
-
项目类别:
-
资助金额:$77.21万
-
财政年份:2021
-
负责人:Catherine A Blish
-
依托单位:
Natural killer cell engineering to target the HIV reservoir
-
批准号:10593137
-
项目类别:
-
资助金额:$76.01万
-
财政年份:2021
-
负责人:Catherine A Blish
-
依托单位:
Targeting natural killer cells to HIV in intravenous drug users
-
批准号:10347303
-
项目类别:
-
资助金额:$78.5万
-
财政年份:2018
-
负责人:Catherine A Blish
-
依托单位:
Diagnostic signatures of Zika virus pathogenesis
-
批准号:9298458
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2017
-
负责人:Catherine A Blish
-
依托单位:
Harnessing natural killer cell memory to fight viruses
-
批准号:8571323
-
项目类别:
-
资助金额:$238.66万
-
财政年份:2013
-
负责人:Catherine A Blish
-
依托单位:
Modeling the influence of sex on natural killer cell networks
-
批准号:8994014
-
项目类别:
-
资助金额:$9.87万
-
财政年份:2013
-
负责人:Catherine A Blish
-
依托单位:
Defining Immune Deficits in HIV-1 Infected Women
-
批准号:7766258
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2006
-
负责人:Catherine A Blish
-
依托单位:
Defining Immune Deficits in HIV-1 Infected Women
-
批准号:7192411
-
项目类别:
-
资助金额:$11.29万
-
财政年份:2006
-
负责人:Catherine A Blish
-
依托单位:
Defining Immune Deficits in HIV-1 Infected Women
-
批准号:7379920
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2006
-
负责人:Catherine A Blish
-
依托单位:
Defining Immune Deficits in HIV-1 Infected Women
-
批准号:7575166
-
项目类别:
-
资助金额:$12.37万
-
财政年份:2006
-
负责人:Catherine A Blish
-
依托单位:
Defining Immune Deficits in HIV-1 Infected Women
-
批准号:7062272
-
项目类别:
-
资助金额:$11.29万
-
财政年份:2006
-
负责人:Catherine A Blish
-
依托单位:
海外基金